Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday

Author: Avi Kapoor | June 28, 2024 09:17am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • JP Morgan analyst Matthew Boss downgraded NIKE, Inc. (NYSE:NKE) from Overweight to Neutral, while cutting the price target from $116 to $83. Nike shares gained 0.1% to close at $94.19 on Thursday. See how other analysts view this stock.
  • Argus Research analyst David Toung downgraded the rating for Charles River Laboratories International, Inc. (NYSE:CRL) from Buy to Hold. Charles River shares gained 0.3% to close at $207.35 on Thursday. See how other analysts view this stock.
  • Stifel analyst Jim Duffy downgraded the rating for NIKE, Inc. (NYSE:NKE) from Buy to Hold and slashed the price target from $117 to $88. Nike shares gained 0.1% to close at $94.19 on Thursday. See how other analysts view this stock.
  • Needham analyst Ryan Koontz downgraded Infinera Corporation (NASDAQ:INFN) from Buy to Hold. Infinera shares rose 1.5% to settle at $5.26 on Thursday. See how other analysts view this stock. See how other analysts view this stock.
  • Morgan Stanley analyst Alex Straton downgraded NIKE, Inc. (NYSE:NKE) from Overweight to Equal-Weight, while lowering the price target from $114 to $79. Nike shares gained 0.1% to close at $94.19 on Thursday.  See how other analysts view this stock.

Check This Out: Top 3 Real Estate Stocks You’ll Regret Missing In June

Posted In: CRL INFN NKE